| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |